Cristina Cusin, MD
Psychiatry · Boston, MANPI 1003942426
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Livanova USA, Inc. at 47.3% of the total. Reporting peaked in 2024 at $7,276 and has fallen 64.6% since, to $2,574 in 2025. Among psychiatry clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $503.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$8K
- Johnson & Johnson$6K
- Boehringer Ingelheim$3K
- Abbott$336
- Janssen Scientific Affairs, LLC$74
- Biogen$49
Across 185 payments — averaging $1690.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$292K
- Janssen Research & Development, LLC$21K
What the payments were for
- Consulting fees$7,27542%
- Speaking & faculty fees$5,20030%
- Travel & lodging$3,62721%
- Food & beverage$1,0226%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 14 | $8,106 |
| Johnson & Johnson | 8 | $6,012 |
| Boehringer Ingelheim | 6 | $2,546 |
| Abbott | 3 | $336 |
| Janssen Scientific Affairs, LLC | 2 | $74 |
| Biogen | 1 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy Symmetry Model 8103 Generator$6,816
- SPRAVATO$5,901
- VNS Therapy$963
- INFINITY$327
How this compares
$17,123 in reported general payments places this provider in the 95th percentile of 1,431 psychiatry providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $108,736 |
| TrintellixVortioxetine Hydrobromide | 26 | $24,965 |
| Effexor XrVenlafaxine Hcl | 13 | $18,499 |
| Methylphenidate ErMethylphenidate Hcl | 30 | $1,346 |
| Bupropion XlBupropion Hcl | 25 | $1,016 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 13 | $732 |
| Lamotrigine | 21 | $574 |
| Clonazepam | 52 | $573 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 33 | $510 |
| Methylphenidate Hcl | 29 | $464 |
| Duloxetine Hcl | 18 | $445 |
| Clozapine | 21 | $375 |
| Bupropion Hcl | 19 | $309 |
| Mirtazapine | 11 | $299 |
| Quetiapine Fumarate | 19 | $221 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Boston
- Ximena Sanchez-SamperBoston$258K
- George PapakostasBoston$170K
- Maurizio FavaBoston$120K
- Andrew NierenbergBoston$94K
- Lee GoldsteinBoston$90K
- Gary SachsBoston$81K
- Dan IosifescuBoston$61K
- Lee CohenBoston$51K
- Michael OstacherBoston$39K
- Cristina MontalvoBoston$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.